Upstream and Downstream Targeting of the Complement Pathway to Manage PNH: Current and Emerging Inhibitors
0.50 hr(s) | CME
Therapeutic Area(s): Hematology, Benign , Oncology
Release Date: December 31, 2021
Expiration Date: December 30, 2022
Location: Internet Activity Enduring
In this activity, an expert in hematology-oncology provides an overview of paroxysmal nocturnal hemoglobinuria (PNH) and discusses current and emerging treatment options for managing PNH.